[A differential approach to cavinton and finoptin treatment of patients with circulatory encephalopathies].
Burtsev
E M
EM
Shprakh
V V
VV
Savkov
V S
VS
D000368:Aged; D002560:Cerebrovascular Circulation / Q000187:drug effects; D002561:Cerebrovascular Disorders / Q000188:drug therapy*; D006801:Humans; D008875:Middle Aged; D010726:Phosphodiesterase Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D014665:Vasodilator Agents / Q000494:pharmacology / Q000627:therapeutic use*; D014700:Verapamil / Q000494:pharmacology / Q000627:therapeutic use*; D014748:Vinca Alkaloids / Q000494:pharmacology / Q000627:therapeutic use*
D010726:Phosphodiesterase Inhibitors; D014665:Vasodilator Agents; D014748:Vinca Alkaloids; C013983:vinpocetine; D014700:Verapamil
O differentsirovannom podkhode k naznacheniiu kavintona i finoptina bol'nym distsirkuliatornoĭ éntsefalopatieĭ.